What is ovarian hyperstimulation syndrome (OHSS), and how can it be prevented in IVF?
IVF Questions & Answers
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
What is ovarian hyperstimulation syndrome (OHSS), and how can it be prevented in IVF?
Ovarian Hyperstimulation Syndrome (OHSS) is a potentially serious complication from fertility treatments like IVF. It results from excessive ovarian response to stimulation. Preventive measures include using a lower dose of hormones and monitoring estrogen levels closely during treatment.
Ovarian hyperstimulation syndrome (OHSS) is a potential complication that can occur as a result of ovarian stimulation during in vitro fertilization (IVF) treatment. It is characterized by the enlargement of the ovaries and the accumulation of fluid in the abdominal cavity and sometimes in the chest. OHSS can range from mild to severe, with symptoms that may include abdominal pain or bloating, nausea, vomiting, and in severe cases, shortness of breath and decreased urination.
Prevention of OHSS is an essential aspect of IVF treatment to minimize the risks associated with this condition. Here are some strategies that can be employed to prevent OHSS:
1. Monitoring Ovarian Response: Regular monitoring through blood tests and ultrasounds during the IVF cycle can help to closely track the response of the ovaries to stimulation. This allows for adjustments in medication dosages to prevent overstimulation.
2. Individualized Treatment Protocols: Tailoring the stimulation protocols to the individual’s characteristics, such as age, ovarian reserve, and previous response to stimulation, can help in reducing the risk of OHSS.
3. Trigger Shot Adjustment: The timing and dosage of the trigger shot (hCG injection) can be modified based on the individual’s risk factors for developing OHSS. Using a different trigger medication like a GnRH agonist instead of hCG can also help reduce the risk of severe OHSS.
4. Freeze-all Approach: In cases where there